Deleted Tweets From Scott Gottlieb, R-D.C.

@statnews @US_FDA @ScottGottliebMD Thanks @RebeccaDRobbins and @statnews -- I'll try to use more Emojis in 2018

.@OpenFDA was launched in June 2014 to provide the public access to files of a number of high-value agency datasets, including adverse events and recall enforcement. Congrats to the team for recently fulfilling 75 million data requests https://t.co/YYjoHf

RT @US_FDA: FDA Commissioner @SGottliebFDA on latest steps FDA is taking to create more efficient generic drug review, meant to… https://t.co/4c2w2Xz7X8

FederalNewsRadio: The #FDA is "redesigning its hiring process" and is beginning "a brand new pilot that will attempt to resolve frustrations from agency hiring managers and its own applicants." https://t.co/vFBYHhYnIc

RT @FDA_Track: Statement from FDA Commissioner Scott Gottlieb, M.D. on new steps to facilitate efficient generic drug review to en… https://t.co/7WtnNkDgyx

RT @RAPSorg: .@US_FDA Targets Multiple Review Cycles With New Draft Guidance, MAPP | #Regulatory Focus https://t.co/5jkBMKpdIp #FDA #pharma #genericdrugs

RT @califf001: Bravo. We should be helping legitimate stem cell tx based on high quality evidence and stopping efforts to promote unproven… QT @SGottliebFDA: We will continue to intervene when we see unapproved products putting patients at risk https://t.co/AX9hnfMjea)

RT @FDAMedia: Statement from FDA Commissioner @SGottliebFDA on FDA Food Safety Modernization Act enforcement discretion guidance. https://t.co/ZmSQ3e2D8J

@US_FDA We’re committed to ensuring the U.S. food supply remains among the safest in the world https://t.co/odEe7FZLUh

@US_FDA #FDA will continue its collaboration with the states, industry and other stakeholders to ensure #FSMA is implemented in the most efficient, effective and enduring way; while prioritizing our public health goals

Today @US_FDA issued guidance on areas of #FSMA where #FDA is exercising enforcement discretion to allow more time to consider better approaches, long-term solutions for challenging areas. Our goal? To get a framework that works for the long run: https://

RT @FDAWomen: Newborn screening helps detect diseases that are usually hidden at birth. How @US_FDA ensures these tests’ safety:… https://t.co/GF0QUhst9m

RT @steveusdin1: Charting FDA’s recent progress and ongoing campaigns in NGS dx. FDA has solidified its commitment to advancing gene… https://t.co/9cAO0jep11

We owe gratitude to local officials in Puerto Rico who worked with #FDA to help prioritize public health issues, including the governor and his staff. We also had a close collaboration with #DHS and are grateful to our partners there

This is going to be a very long recovery and #FDA’s work in Puerto Rico is far from over. There are still product risks; and the island’s economic recovery is dependent on reclaiming its manufacturing sector. We’re committed to helping #PR restore it

RT @FDATobacco: Smoking can increase a woman’s risk for cervical cancer. Protect your health and stay #smokefree.… https://t.co/FRpmck02Q2

In Puerto Rico, all of the medical product facilities that #FDA was concerned about - where we worried shortages of critical products could - are now back on the grid. We remain committed to the islands long term recovery https://t.co/bBOkKRbNOk

RT @FDA_Drug_Info: Need real-time information about #DrugShortages? Download the Drug Shortages Mobile Application for easier and fast… https://t.co/dMk7MdRW8l

RT @krebs_matt: With a slew of landmark approvals in the last 18 months, @US_FDA has solidified its commitment to advancing genetic… https://t.co/0sPAOoVHik

Data visualization shows #FDA collaboration on #oncology publications with institutions in the U.S. and worldwide since 2008. Orange dots are FDA campus in Silver Spring, MD, and FDA/NCTR in Arkansas #OCEpubs https://t.co/FhY3CT8ZMj

@statnews @US_FDA @ScottGottliebMD Thanks @RebeccaDRobbins and @statnews -- I'll try to use more Emojis in 2018

.@OpenFDA was launched in June 2014 to provide the public access to files of a number of high-value agency datasets, including adverse events and recall enforcement. Congrats to the team for recently fulfilling 75 million data requests https://t.co/YYjoHf

RT @US_FDA: FDA Commissioner @SGottliebFDA on latest steps FDA is taking to create more efficient generic drug review, meant to… https://t.co/4c2w2Xz7X8

FederalNewsRadio: The #FDA is "redesigning its hiring process" and is beginning "a brand new pilot that will attempt to resolve frustrations from agency hiring managers and its own applicants." https://t.co/vFBYHhYnIc

RT @FDA_Track: Statement from FDA Commissioner Scott Gottlieb, M.D. on new steps to facilitate efficient generic drug review to en… https://t.co/7WtnNkDgyx

RT @RAPSorg: .@US_FDA Targets Multiple Review Cycles With New Draft Guidance, MAPP | #Regulatory Focus https://t.co/5jkBMKpdIp #FDA #pharma #genericdrugs

RT @califf001: Bravo. We should be helping legitimate stem cell tx based on high quality evidence and stopping efforts to promote unproven… QT @SGottliebFDA: We will continue to intervene when we see unapproved products putting patients at risk https://t.co/AX9hnfMjea)

RT @FDAMedia: Statement from FDA Commissioner @SGottliebFDA on FDA Food Safety Modernization Act enforcement discretion guidance. https://t.co/ZmSQ3e2D8J

@US_FDA We’re committed to ensuring the U.S. food supply remains among the safest in the world https://t.co/odEe7FZLUh

@US_FDA #FDA will continue its collaboration with the states, industry and other stakeholders to ensure #FSMA is implemented in the most efficient, effective and enduring way; while prioritizing our public health goals

Today @US_FDA issued guidance on areas of #FSMA where #FDA is exercising enforcement discretion to allow more time to consider better approaches, long-term solutions for challenging areas. Our goal? To get a framework that works for the long run: https://

RT @FDAWomen: Newborn screening helps detect diseases that are usually hidden at birth. How @US_FDA ensures these tests’ safety:… https://t.co/GF0QUhst9m

RT @steveusdin1: Charting FDA’s recent progress and ongoing campaigns in NGS dx. FDA has solidified its commitment to advancing gene… https://t.co/9cAO0jep11

We owe gratitude to local officials in Puerto Rico who worked with #FDA to help prioritize public health issues, including the governor and his staff. We also had a close collaboration with #DHS and are grateful to our partners there

This is going to be a very long recovery and #FDA’s work in Puerto Rico is far from over. There are still product risks; and the island’s economic recovery is dependent on reclaiming its manufacturing sector. We’re committed to helping #PR restore it

RT @FDATobacco: Smoking can increase a woman’s risk for cervical cancer. Protect your health and stay #smokefree.… https://t.co/FRpmck02Q2

In Puerto Rico, all of the medical product facilities that #FDA was concerned about - where we worried shortages of critical products could - are now back on the grid. We remain committed to the islands long term recovery https://t.co/bBOkKRbNOk

RT @FDA_Drug_Info: Need real-time information about #DrugShortages? Download the Drug Shortages Mobile Application for easier and fast… https://t.co/dMk7MdRW8l

RT @krebs_matt: With a slew of landmark approvals in the last 18 months, @US_FDA has solidified its commitment to advancing genetic… https://t.co/0sPAOoVHik

Data visualization shows #FDA collaboration on #oncology publications with institutions in the U.S. and worldwide since 2008. Orange dots are FDA campus in Silver Spring, MD, and FDA/NCTR in Arkansas #OCEpubs https://t.co/FhY3CT8ZMj